IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 18.260
NA - Nord America 4.477
EU - Europa 1.872
SA - Sud America 105
AF - Africa 73
OC - Oceania 70
AN - Antartide 3
Totale 24.860
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 12.834
US - Stati Uniti d'America 4.250
HK - Hong Kong 2.678
CN - Cina 2.360
GB - Regno Unito 760
IT - Italia 326
DE - Germania 238
CA - Canada 161
IN - India 157
BR - Brasile 79
NL - Olanda 77
FI - Finlandia 74
AU - Australia 65
JP - Giappone 58
ZA - Sudafrica 56
UA - Ucraina 55
MX - Messico 54
PL - Polonia 49
TR - Turchia 43
ES - Italia 41
FR - Francia 38
CZ - Repubblica Ceca 32
SE - Svezia 30
ID - Indonesia 23
CH - Svizzera 18
BE - Belgio 17
EE - Estonia 17
LT - Lituania 16
KR - Corea 15
RU - Federazione Russa 13
VN - Vietnam 13
AR - Argentina 10
SA - Arabia Saudita 10
BD - Bangladesh 8
TW - Taiwan 8
AT - Austria 7
EG - Egitto 7
IL - Israele 7
HU - Ungheria 6
PE - Perù 6
PT - Portogallo 6
RO - Romania 6
SK - Slovacchia (Repubblica Slovacca) 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
PH - Filippine 5
SI - Slovenia 5
AL - Albania 4
CL - Cile 4
DM - Dominica 4
LU - Lussemburgo 4
TH - Thailandia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
HR - Croazia 3
KW - Kuwait 3
NG - Nigeria 3
PK - Pakistan 3
RS - Serbia 3
AM - Armenia 2
AQ - Antartide 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
EC - Ecuador 2
IE - Irlanda 2
IQ - Iraq 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TJ - Tagikistan 2
UY - Uruguay 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
MS - Montserrat 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
Totale 24.854
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.660
Hefei 1.393
Singapore 1.304
Ashburn 1.099
Boardman 801
London 669
Shanghai 479
Beijing 260
Dallas 254
Los Angeles 167
San Francisco 164
Council Bluffs 135
Pune 102
Seattle 102
Munich 95
Toronto 93
Santa Clara 83
Washington 66
New York 62
Rome 59
Tokyo 46
Warsaw 46
Turku 41
Amsterdam 40
Brooklyn 37
Mexico City 37
São Paulo 36
Montreal 34
Helsinki 33
Melbourne 32
Chicago 31
Brno 29
Johannesburg 29
Stockholm 25
Boston 24
Chennai 22
Naples 20
Milan 18
Secaucus 17
Sydney 17
Canberra 16
West Jordan 16
Charlotte 14
Phoenix 14
Paris 13
Atlanta 12
Hanover 12
Hasselt 12
Manchester 12
St Louis 12
Ankara 11
Oklahoma City 11
San Jose 11
Guangzhou 10
Haikou 10
Riyadh 9
The Dalles 9
Hyderabad 8
Markham 7
Mumbai 7
Poplar 7
Redmond 7
Sona 7
Topeka 7
Bologna 6
Central 6
Charleston 6
Denver 6
Frankfurt am Main 6
Mong Kok 6
New Delhi 6
Palermo 6
Vienna 6
Baoding 5
Bratislava 5
Buffalo 5
Changsha 5
Florence 5
Handan 5
Honolulu 5
Lima 5
Ljubljana 5
Miami 5
Modena 5
New Taipei 5
San Pietro in Lama 5
Shijiazhuang 5
Yeonsu-gu 5
Budapest 4
Cleveland 4
Crawley 4
Haifa 4
Lincoln 4
Luxembourg 4
Orem 4
Padova 4
Reston 4
Roseau 4
San Ferdinando Di Puglia 4
Tirana 4
Totale 11.092
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 224
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 221
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 204
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 204
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 204
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 204
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 203
Early impairment of food intake in patients newly diagnosed with cancer 200
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 198
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 198
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 196
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 196
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 196
Designing a broad-spectrum integrative approach for cancer prevention and treatment 195
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 194
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 193
Premetastatic niche: ready for new therapeutic interventions? 192
A key opinion leader interview with Prof D Santini: insight into cancer research. 192
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 192
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 192
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 191
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 191
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 190
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 189
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 187
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 187
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 185
Prevention of radiotherapy-induced emesis 183
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 181
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 181
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 181
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 180
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 175
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 174
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 171
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 170
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 167
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 166
Docetaxel induced pericardial effusion 162
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 154
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 140
A giant sarcoma of the parotid gland: A case report and review of the literature 114
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 110
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 110
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 106
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 106
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 105
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 101
Anestesia e malattie non comuni 101
Colorectal carcinomas and PTEN/MMAC1 gene mutations 100
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 100
'Old' and 'new' drugs for the treatment of cancer pain 100
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 98
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 95
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 95
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 95
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 93
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 92
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 91
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 91
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 91
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 91
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 90
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 90
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 90
Biological effects of cabozantinib on bone microenvironment 90
Idiosyncratic reaction after oxaliplatin infusion 89
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 89
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 89
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 88
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 88
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 88
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 88
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 88
[Treatment of stage-I seminoma. Critical review] 87
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 87
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 86
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 86
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 86
Atypical chronic head and neck pain: don't forget Eagle's syndrome 86
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 85
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 83
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 82
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 82
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 81
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 81
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 79
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 79
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 79
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 78
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 77
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 73
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 69
Classic Kaposi Sarcoma: to treat or not to treat? 67
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 66
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 63
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 58
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib 54
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 54
Totale 12.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.010 0 4 5 8 73 10 15 4 42 20 23 806
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.297 52 281 95 171 239 1.039 17 154 23 59 75 92
2024/202518.581 335 274 924 147 171 511 315 63 1.959 1.581 5.758 6.543
2025/20262.902 1.876 777 249 0 0 0 0 0 0 0 0 0
Totale 24.993